ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
123 hedge funds and large institutions have $1.21B invested in Alder Biopharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 52 increasing their positions, 27 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
1% less funds holding
Funds holding: 124 → 123 (-1)
5% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 21
Holders
123
Holding in Top 10
4
Calls
$750K
Puts
$373K
Top Buyers
| 1 | +$73.6M | |
| 2 | +$31.5M | |
| 3 | +$23.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$19M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$18.4M |
Top Sellers
| 1 | -$8.8M | |
| 2 | -$7.71M | |
| 3 | -$4.62M | |
| 4 |
Citigroup
New York
|
-$4.29M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.4M |